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Introduction
Obesity is a prevalent issue that affects millions all over the world. Comparing with 29.8% of women who were overweight (body mass index [BMI] >25 kg/m 2 ) in 1980, the proportion of overweight women worldwide had increased to 38% in 2013 [1] . A number of studies had pointed overweight and obesity as major causes of chronic diseases such as hypertension, cardiovascular disease, abnormal lipid concentrations, and type 2 diabetes [2, 3] . In particular, evidence has elucidated that obesity has an adverse impact on reproduction. Despite the complications of pregnancy including miscarriage, gestational diabetes and hypertensive disorders induced by obesity, it appears that overweight and obesity are more likely to have anovulatory infertility than normal-weight women [4, 5] .
With regard to the effects of a raised BMI on the outcome of assisted reproduction technology (ART), early studies documented that BMI had no influence on in vitro fertilization (IVF) outcomes, which was argued by more recent researches that suggested an opposite conclusion [6] [7] [8] . The influence of obesity on the outcomes of IVF/ intracytoplasmic sperm injection (ICSI) remains controversial. Studies have stated that elevated BMI was associated with lower clinical pregnancy rates, higher miscarriage rates, and reduced live birth rates [9, 10] . A retrospective data from 488 IVF cycles of 385 patients demonstrated that BMI had no effect IVF/ICSI outcomes [11] . Another study found that the rates of pregnancy and live birth were reduced progressively with each unit of BMI (kilograms per square meter) without affecting embryo quality [12] . In the setting of IVF, increased doses of gonadotropin for inducing ovulation or stimulating the ovaries to obtain mature oocytes were required in obese women [6, 13] . Impaired ovarian responsiveness to gonadotropin stimulation and reduced number of oocytes retrieved were reported to be associated with obesity [14, 15] .
Polycystic ovary syndrome (PCOS) is influencing 4-6% of women [16, 17] . Of the patients with PCOS, about half of them are obese [18] . Reduction of weight could improve fertility in PCOS patients who attempted spontaneous conception [19, 20] . To date, the impact of BMI on ART outcomes in PCOS patients has not been fully demonstrated. A previous investigation showed that obesity and PCOS were independently associated with smaller oocyte diameter among patients undergoing ICSI [21] . PCOS patients with low BMI had more favorable ART cycle characteristics compared to patients with higher BMI but showed no significant difference [22] .
Therefore, this study was aimed to investigate the effect of BMI on the outcomes of IVF/ICSI-ET by comparing the number of retrieved oocytes, implantation rate, clinical pregnancy rate, miscarriage rate and live births between PCOS and non-PCOS patients using prospectively collected clinical data.
Materials and Methods

Patients
A retrospective cohort study of was performed in the patients who received assisted reproduction in the Second Hospital of Hebei Medical University from July 2012 to December 2013. A total of 2256 cycles were included in this study, of them 1848 cycles were non-PCOS patients and 408 cycles were PCOS patients. All patients were under 35 years old. All patients agreed with our data utilization, and signed informed, written consent forms before this investigation. This study was approved by the ethics committee of The Second Hospital of Hebei Medical University (#68-06-2009).
Definition of overweight and obesity
The height and weight of all subjects were measured by medical assistants using standardized protocols as per clinical practice. BMI was calculated according to the standard formula: BMI = weight/ height 2 (kg/m 2 )
. BMI values between 24 and 28 kg/m 2 were defined as overweight and BMI ≥28 kg/m 2 was defined as obesity [23, 24] . Individual BMI was compared to the age-and sex-specific cutoff points, and the resulting status (normal, overweight, or obese) was recorded. 
Clinical assessment
Before IVF/ICSI cycle, basic characteristics of each patient were collected, including weight, height, age, infertility duration, infertility type, comprehensive medical history and reproductive history. After the initial consultation, women underwent an infertility evaluation that included a physical examination; a 1-month menstrual cycle diary with a urine ovulation predictor kit provided to detect the luteinizing hormone (LH) surge; uterine/oviduct imaging; and biochemical testing to document ovarian reserve and occurrence of ovulation and to rule out other endocrine and structural abnormalities.
IVF protocol
Patients were selected for IVF or ICSI cycle according to standard accepted indications [25] . Individual physician of patient determined the IVF protocol used for controlled ovarian hyperstimulation during each cycle. Basically, for patients without PCOS, 0.05-0.1mg decapeptyl was given per day from day 7 of the cycle before controlled ovarian hyperstimulation. The gonadotropin dose was chosen based on age, antral follicle count, and previous response to gonadotropins of patients. For PCOS patients, one tablet of Diane-35 (2 mg cyproterone acetate and 35 µg ethinylestradiol per tablet) was given per day from day 3 to 5 of the cycle before controlled ovarian hyperstimulation. After 16 days of Diane-35 administration, 0.05 mg decapeptyl was subcutaneously injected per day for 14 days. Cycle monitoring was performed with ultrasonography ovarian transvaginal and serum estradiol measurements and the frequency of monitoring was dependent of the ovarian response to ovarian hyperstimulation. When two or more lead follicles exceeded 18 mm, human chorionic gonadotropin (HCG) 10,000 IU was administered for final maturation of the oocytes and the oocyte retrieval was conducted approximately 35 h later. Embryos were transferred to the uterus either 3 days (cleavage stage) or 5 days (blastocyst stage) after oocyte retrieval. The embryos generated from each cycle were graded according to their morphologic characteristics.
Outcomes
Clinical outcomes included implantation rate, biochemical pregnancy rate, clinical pregnancy rate, abortion rate, preterm birth rate and term birth rate. Chemical pregnancy was defined as a positive serum β human chorionic gonadotropin without progression of a pregnancy prior to sonographic evidence of fetal cardiac activity. A clinical pregnancy was documented by sonographic evidence of fetal cardiac activity. Abortion was denoted by the loss of a clinical pregnancy prior to 20 weeks' gestational age. A live birth was defined as the delivery of a viable infant. Other cycle parameters, such as duration of stimulation, total dose of gonadotropins, number of oocytes retrieved, number of two-pronuclear zygotes (2PN) embryos, number of transferrable embryos, and cleavage rate were also compared.
Statistical analysis
Outcome measures between groups were compared using Student's t test and chi-square tests where appropriate. To compare the differences of the variables between the groups, one-way ANOVA analysis followed by a Tukey's post hoc test was conducted. Analyses were performed using Statistical Analysis Software (SAS) version 8.0 (SAS Institute, Inc, Cary, NC). P < 0.05 was considered statistically significant.
Results
A total of 2, 256 women who were suffering from infertility and received IVF/ICSI were retrospectively analyzed in this study. All patients were evaluated and treated at the Second Hospital of Hebei Medical University. Women included were aged below 35 years and having their first IVF/ICSI cycle using autologous oocytes and had a BMI recorded in their electronic medical chart. Cases included 149 patients who were underweight (BMI<18.5 kg/m . The information of all the patients were shown in Table 1 . We found that the mean baseline of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2) significantly decreased whereas the level of testosterone (T) was significantly elevated with BMI increasing. Compared to normal weight patients, patients who were underweight Table 2 ). However, obesity led to significant increases in the number of retrieved We further analyzed the differences of gonadotropin treatment and IVF/ICSI outcomes between the four groups. The duration and dosage of gonadotropin were increased in obese patients compared to them in other patients (p<0.01, Table 3 ). In contrast, implantation rate significantly reduced with BMI increasing from 37.94% in normal BMI patients to a low of 27.45% in obese patients (p<0.01). There was no significant difference of biochemical pregnancy rate between the groups. A significant low clinical pregnancy rate was observed in obese patients compared to the other groups (p<0.01). In obese patients, 24.72% had abortion whereas 11.26% of normal BMI patients suffered from spontaneous abortion during infertility treatment. Although there was no significant difference in preterm birth rate between the groups, patients who were either underweight or overweight had significantly lower term birth rate compared to normal BMI patients (p<0.05). These results suggest that abnormal BMI had an adverse effect on the outcomes of IVF/ICSI-ET. 
Subgroup Analysis
Non-PCOS patients. In order to seek for the influence of PCOS on the outcomes of IVF/ ICSI-ET in obese patients, we divided the patients into two groups, group B and group C, non-PCOS and PCOS patients respectively. Consistently, in group B, the basal level of FSH, LH and E2 were significantly decreased with BMI increasing (Table 4) . T level was increased in obese patients compared to it in normal BMI patients (p<0.01). Additionally, the numbers of retrieved oocytes and transferrable embryos were significantly reduced in either underweight (p<0.05) or obese patients (p<0.01) compared to the numbers in normal BMI patients ( Table  5) . Obese patients in group B received significantly higher dosage of gonadotropin than other patients (p<0.01, Table 6 ). However, the implantation rate was reduced with BMI increasing. Abortion rate in obese patients were significantly higher than it in other groups. Less term birth rate was observed in underweight and overweight patients compared to normal BMI patients (p<0.01). 
PCOS patients
The same analysis was performed in PCOS patients. Compared to patients without PCOS, no significant differences of the basal levels of FSH, LH and E2 were observed between the groups (Table 7) . Consistently, T level was significantly increased as the trend in non-PCOS patients (Table 8 ). The numbers of retrieved oocytes, 2PN embryos and transferrable embryos were all significantly declined with BMI increasing in PCOS patients. In comparison with non-PCOS patients, longer and higher dosages of gonadotropin were applied in patients with higher BMI (Table 9 ). However, the implantation rate and clinical pregnancy rate were not improved but inversely decreased in overweight and obese patients compared to them in or normal or low BMI patients. However, the abortion rate was elevated with BMI increasing. We found that BMI had no influence on term birth rates in PCOS patients.
Discussion
Obesity has become a worldwide issue and the proportion of obese women is increasing [26] . As obesity has been shown to adversely affect reproduction, there are a number of studies seeking for the impact of obesity on the outcomes of IVF/ICSI. However, the conclusions are conflicting. In present study, patients under 35 years were selected and divided into four groups based on their BMIs. The effect of PCOS was investigated by comparing the outcomes of IVF/ICSI between patients with and without PCOS. We found that the basal levels of FSH, LH and E significantly decreased whereas the level of T was significantly elevated with BMI increasing in normal patients. However, in PCOS patients, only T level was significantly elevated with BMI increasing. In addition, abnormal weight led to reduced number of retrieved oocytes in non-PCOS patients. The adverse effect of PCOS on maturation of oocytes may be attenuated by reduced weight because no significant difference of the number of retrieved oocytes was observed between normal weight and underweight patients. Although the implantation rates were both decreased in PCOS and non-PCOS patients with BMI increasing, clinical pregnancy rate were significantly reduced with abnormal high BMI in PCOS patients but not non-PCOS patients.
PCOS is a common endocrine disorder characterized by insulin resistance, hyperandrogenism, ovulatory dysfunction and polycystic ovary [27, 28] . About 15% women of reproductive age are diagnosed by Rotterdam criteria [29] . Women with PCOS may be confronted with infertility and menstrual irregularities because of endocrine abnormalities that affect ovulatory function, oocyte quality, and endometrial receptivity [29] . Additionally, obesity is reported in more than 60% patients with PCOS, which increases the risk and condition of infertility [30] . Women with PCOS frequently shows elevated LH levels due to lack of progesterone and hyperandrogenaemia that can attenuate the progesterone negative feedback effect [31, 32] . High level of LH was proposed to be associated with premature luteinization and anovulation. In contrast to elevated LH level, FSH level was decreased in PCOS women [33] . It was observed that obese women with PCOS exhibited a blunted LH secretion via certain mechanisms acting at the pituitary level [34] , suggesting increased LH level may be the main cause of anovulation in lean PCOS women. Insulin resistance is a predominant feature of PCOS, which can be enhanced by obesity in PCOS women. Higher level of insulin resistance and compensatory hyperinsulinaemia contribute to hyperandrogenism in PCOS and leads to the increase of T [35] , arresting folliculogenesis through inhibition of granulosa cell proliferation and maturation, oestrogen and progesterone secretion and leading to anovulatory infertility [36] . A previous study on female rats revealed that androgen level may play an important role in liver metabolism and triglycerides level was also elevated in androgenized prepubertal rats compared to non-androgenized rats [37] , which may provide a clue about the correlation between PCOS and obesity. In this study, we found that the basal levels of FSH and LH were significantly reduced in obese non-PCOS patients. Compared to normal patients, PCOS patients showed relatively higher basal levels of LH and T but lower basal levels of FSH and E2. Ovarian hyperstimulation syndrome (OHSS) was stated to exhibited significantly lower level of basal LH [38] . To evidence the poor outcomes of IVF were not induced by OHSS, assessments such as measuring serum microRNA (miRNAs) miR-223 are necessary in further investigation. Additionally, miRNAs miR-222, miR-146a and miR-30c could also be assessed in further study as they were reported as biomarkers of PCOS [39] , because the correlation between these miRNAs and BMI may affect IVF outcomes. However, basal T level was significantly elevated with BMI increasing in all patients. It was found that hepatic fetuin-A expression is regulated by testosterone via androgen receptor and fetuin-A leads to insulin resistant and is associated with PCOS [40] . Therefore, elevated T level in overweight and obese patients may play an important role in infertility and poor IVF outcomes.
In the setting of IVF/ICSI cycle, a higher number of oocyte retrieved was observed in PCOS patients compared to it in normal patients [41] , which was consistently supported by our data. A cohort analysis on 1417 cycles with 487 patients indicated the number of oocytes retrieved was negatively correlated with BMI increasing and the dose of gonadotropin [14] . While high level of leptin inhibit FSH secretion in obese patients and suppress the secretion of estrogen from theca cells [42] , obese PCOS women was found to be associated with reduced number of oocytes retrieved [43] [44] [45] . However, the relationship between obesity, PCOS and the outcomes of IVF/ICSI remains controversial. In this study, we demonstrated that significant decrease of retrieved oocytes was associated with BMI increase in PCOS patients. The inconsistent conclusion may be caused by the differences between populations and cut-off points for BMI. Miscarriage rates in both PCOS and non-PCOS patients were raised with the increase of BMI, which were accompanied by decreases in implantation rates with BMI increasing. According to the reduced number of transferrable embryos in lean and obese patients without PCOS, it can be implied that abnormal weight affects the quality of oocyte. Previous studies proposed deregulation circulating insulin play an essential role in the maturation and quality of oocyte [46, 47] . Either lean or obese women exhibited a negative impact on oocyte quality [48, 49] .
We found that duration and dosage of gonadotropin were significantly increased in overweight and obese PCOS patients. Although studies demonstrated that no change of gonadotropin treatment was implied in different BMI [50, 51] , there are several studies have argued that higher dosage of gonadotropin and longer treatment duration exhibited in patients with BMI more than 25 kg/m 2 [52, 53] . Interestingly, in our results, no significant difference on clinical pregnancy rate was observed by the change of BMI in non-PCOS patients whereas overweight and obese women with PCOS showed significant decrease in clinical pregnancy rate, suggesting BMI may affect the outcome of IVF/ICSI only in PCOS patients. Previous data proposed that BMI may impair the function of endometrium and reduce endometrial receptivity; and poor outcome of IVF/ICSI was correlated with high BMI [54, 55] . These findings were not consistent with our results, which may be the distinguishing inclusion criteria of patients. A recent study also demonstrated that higher BMI significantly reduced clinical pregnancy rate [56] . Nevertheless, several studies have considered the factors of male BMI, stating that high BMI may affect IVF/ICSI outcomes. Therefore, further analysis is necessary to consider the impact from males on the IVF/ICSI outcomes.
In conclusion, not only obesity but also underweight can impact the outcomes of IVF/ ICSI. For patients with PCOS, elevated BMI significantly reduced clinical pregnancy rate and increased miscarriage rate, giving rise to poor IVF/ICSI outcomes. However, the conclusions on the effect of BMI on IVF/ICSI outcomes remain controversial, which may be caused by different inclusion criteria and the cutoff point of BMI. Since PCOS is usually accompanied by obesity, it is important to reduce BMI in PCOS patients for achieving better outcomes of IVF/ICSI.
